UCB signs $1.1bn to autoimmune collaboration with Chinese biotech Antengene
By Catherine Eckford (European Pharmaceutical Review)
Nanoparticle–ultrasound combo could boost drug release in bacterial biofilms
By Catherine Eckford (European Pharmaceutical Review)
Blueprint’s rare disease drug Ayvakit shows long-term benefit
By Catherine Eckford (European Pharmaceutical Review)
First mRNA COVID-19/flu combination vaccine set for European approval
By Catherine Eckford (European Pharmaceutical Review)
Applying AI to enhance drug formulation and development
By Sanjay Konagurthu (Thermo Fisher Scientific)
Accelerating consistent, stable cell line development with targeted integration
By Fei Chen (WuXi Biologics), Hang Zhou (WuXi Biologics), Tao…






























